September 1, 2014     Japanese 
  JCN 
	  Network - Home
JCN Newswire
  Home  |  Companies  | Annual Reports  |  CSR  | News Alerts     
Company
News Sectors
Automotive
Communications
Consumers
CSR
Electronics
Energy
Environment
Financial
Health & Med
Industrial
IT & Internet
Materials
Real Estate
Science & Research
Telecoms
Trade
Transportation
Departments
Annual Reports
Companies
News Alerts
News Search
Photo Gallery
Company Login
Japan Corporate News Network
About JCN
Privacy Policy
RSS  
Terms of Use
 
 
News Search

The results of your word search

Headline News

Dainippon Sumitomo Pharma Establishes Anti-Cancer Drugs Sales Company in the U.S. (Oct 10, 2013)

Dainippon Sumitomo Pharma Opens Subsidiary in Singapore (Jan 22, 2013)

Kobe University, KNC Labs and Dainippon Sumitomo to Research Anti-cancer Agent (Dec 28, 2012)

Dainippon Sumitomo, AstraZeneca to Develop Antiallergic Drug (May 8, 2008)

Dainippon Sumitomo Pharma Enters into Partnership Agreement on Anti-Hypertension and Hepatocellular Cancer Drugs (July 26, 2006)

Dainippon Sumitomo Pharma to Release AmBisome 50mg, Antifungal Agent for Deep-seated Mycosis Infection (June 16, 2006)

Dainippon Sumitomo Pharma Licenses Precursor of Norepinephrine to Chelsea Therapeutics International (June 5, 2006)

Dainippon Sumitomo Pharma Announces Results of Clinical Trial of Mosapride Citrate (Apr 27, 2006)

Dainippon Sumitomo Pharma Receives Approval for Antifungal Agent AmBisome (Apr 21, 2006)

Dainippon Sumitomo Pharma Receives Approval for Orally Disintegrating Formulation of Amlodin, Hypertension/Angina Pectoris Treatment (Mar 20, 2006)

more...
Press Release News

NOTICE of establishment of Drug Discovery Consortium in neuropsychiatric area (Oct 23, 2008)

Dainippon Sumitomo Pharma Review of Overseas Development of Lurasidone (SM-13496), an Atypical Antipsychotic (Dec 13, 2006)

Dainippon Sumitomo Pharma Revises Domestic Development Plan of AC-5216, an Antianxiety/antidepressant Agent (Nov 28, 2006)

Dainippon Sumitomo Pharma 2006 Annual Report to Shareholders, 'True Quality, Our New Beginning' (Sept 21, 2006)

Dainippon Sumitomo Pharma and Eisai Sign Licensing Agreement for "Gasmotin", a Gastroprokinetic Agent, for Countries in Asia Including ASEAN Members (Apr 17, 2006)

Taisho and Nine Other Companies Announce Approval of OAC Triple Therapy as Helicobacter pylori Eradication Treatment (Apr 12, 2002)

Dainippon and Schering-Plough K.K. Concluded a Co-Marketing Agreement Regarding the Anti-Asthmatic Product, "QVARTM" (Nov 12, 2001)

Dainippon Launches Gasmotin in the People's Republic of China (June 14, 2001)

Dainippon Pharmaceuticals Licenses Out an Antipsychotic Agent (May 15, 2001)

 
CSR Report Download
Most Popular


About JCN | Privacy Policy | Terms of Use | JCN Network (日本語)